Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people

Å Örtqvist, J Hedlund, LÅ Burman, E Elbel, M Höfer… - The Lancet, 1998 - thelancet.com
Background We assessed the effectiveness of a 23-valent pneumococcal vaccine in the
prevention of pneumococcal pneumonia and of pneumonia overall in non-immunocompromised…

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

C Giefing, AL Meinke, M Hanner, T Henics… - The Journal of …, 2008 - rupress.org
Pneumococcus is one of the most important human pathogens that causes life-threatening
invasive diseases, especially at the extremities of age. Capsular polysaccharides (CPSs) are …

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

B Christenson, P Lundbergh, J Hedlund, Å Örtqvist - The Lancet, 2001 - thelancet.com
Background The effectiveness of influenza and pneumococcal vaccination in the prevention
of hospital admissions and death has not been assessed prospectively. We have therefore …

Streptococcus pneumoniae: epidemiology, risk factors, and clinical features

Å Örtqvist, J Hedlund, M Kalin - Seminars in respiratory and …, 2005 - thieme-connect.com
Streptococcus pneumoniae is the most common cause of both pneumonia overall and fatal
pneumonia. Antibiotic resistance has developed worldwide and is most frequent in …

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study …

C Bardage, I Persson, Å Örtqvist, U Bergman… - Bmj, 2011 - bmj.com
… Carola Bardage epidemiologist1, Ingemar Persson professor of pharmacoepidemiology
and senior expert1 2, Åke Örtqvist county medical officer and associate professor3 4, Ulf …

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

M Kalin, Å Örtqvist, M Almela… - The Journal of …, 2000 - academic.oup.com
To define the influence of prognostic factors in patients with community-acquired pneumococcal
bacteremia, a 2-year prospective study was performed in 5 centers in Canada, the …

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

…, P Naucler, M Blennow, Å Örtqvist… - European …, 2016 - Eur Respiratory Soc
The effects of pneumococcal conjugated vaccines (PCVs) need to be investigated. In Stockholm
County, Sweden, PCV7 was introduced in the childhood immunisation programme in …

Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent …

…, E Morfeldt, J Darenberg, Å Örtqvist… - Clinical Infectious …, 2017 - academic.oup.com
Background Pneumococccal conjugated pneumococcal vaccine (PCV10) and pneumococcal
conjugate vaccine 13 (PCV13), are used in childhood immunization programs worldwide, …

Respiratory viruses associated with community-acquired pneumonia in children: matched case–control study

…, M Ryd-Rinder, L Öhrmalm, T Tolfvenstam, Å Örtqvist… - Thorax, 2015 - thorax.bmj.com
Background Community-acquired pneumonia (CAP) is the leading cause of death in children
worldwide and a substantial proportion of childhood CAP is caused by viruses. A better …

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

J Törling, J Hedlund, HB Konradsen, Å Örtqvist - Vaccine, 2003 - Elsevier
Revaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV) has
remained controversial due to lack of immunological data and fear of side effects. We re-vaccinated …